nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.106	0.137	CbGbCtD
Praziquantel—CYP3A7—Paclitaxel—ovarian cancer	0.106	0.137	CbGbCtD
Praziquantel—CYP3A5—Paclitaxel—ovarian cancer	0.0793	0.103	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0764	0.0989	CbGbCtD
Praziquantel—CYP3A7—Docetaxel—ovarian cancer	0.0764	0.0989	CbGbCtD
Praziquantel—CYP2D6—Vinorelbine—ovarian cancer	0.0692	0.0896	CbGbCtD
Praziquantel—CYP3A4—Topotecan—ovarian cancer	0.0625	0.0808	CbGbCtD
Praziquantel—CYP3A5—Docetaxel—ovarian cancer	0.0573	0.0742	CbGbCtD
Praziquantel—CYP3A4—Vinorelbine—ovarian cancer	0.044	0.0569	CbGbCtD
Praziquantel—CYP3A4—Paclitaxel—ovarian cancer	0.0309	0.04	CbGbCtD
Praziquantel—CYP2D6—Doxorubicin—ovarian cancer	0.0262	0.0339	CbGbCtD
Praziquantel—CYP3A4—Docetaxel—ovarian cancer	0.0224	0.0289	CbGbCtD
Praziquantel—CYP3A4—Doxorubicin—ovarian cancer	0.0167	0.0216	CbGbCtD
Praziquantel—Diarrhoea haemorrhagic—Docetaxel—ovarian cancer	0.00699	0.0308	CcSEcCtD
Praziquantel—Diarrhoea haemorrhagic—Epirubicin—ovarian cancer	0.00472	0.0208	CcSEcCtD
Praziquantel—Vertigo—Altretamine—ovarian cancer	0.00449	0.0198	CcSEcCtD
Praziquantel—Diarrhoea haemorrhagic—Doxorubicin—ovarian cancer	0.00436	0.0192	CcSEcCtD
Praziquantel—Convulsion—Altretamine—ovarian cancer	0.00433	0.0191	CcSEcCtD
Praziquantel—Anorexia—Altretamine—ovarian cancer	0.00389	0.0171	CcSEcCtD
Praziquantel—Decreased appetite—Altretamine—ovarian cancer	0.00355	0.0156	CcSEcCtD
Praziquantel—Fatigue—Altretamine—ovarian cancer	0.00352	0.0155	CcSEcCtD
Praziquantel—Asthenia—Altretamine—ovarian cancer	0.00293	0.0129	CcSEcCtD
Praziquantel—Dizziness—Altretamine—ovarian cancer	0.0027	0.0119	CcSEcCtD
Praziquantel—Vomiting—Altretamine—ovarian cancer	0.0026	0.0114	CcSEcCtD
Praziquantel—Nausea—Altretamine—ovarian cancer	0.00243	0.0107	CcSEcCtD
Praziquantel—Bone disorder—Paclitaxel—ovarian cancer	0.00231	0.0102	CcSEcCtD
Praziquantel—Body temperature increased—Carboplatin—ovarian cancer	0.00223	0.00983	CcSEcCtD
Praziquantel—Atrioventricular block—Paclitaxel—ovarian cancer	0.00215	0.00946	CcSEcCtD
Praziquantel—Bone disorder—Docetaxel—ovarian cancer	0.00196	0.00861	CcSEcCtD
Praziquantel—Immune system disorder—Topotecan—ovarian cancer	0.00164	0.00724	CcSEcCtD
Praziquantel—Immune system disorder—Melphalan—ovarian cancer	0.00161	0.00709	CcSEcCtD
Praziquantel—Arrhythmia—Melphalan—ovarian cancer	0.00159	0.00701	CcSEcCtD
Praziquantel—Convulsion—Chlorambucil—ovarian cancer	0.00154	0.00679	CcSEcCtD
Praziquantel—Ill-defined disorder—Topotecan—ovarian cancer	0.00147	0.00647	CcSEcCtD
Praziquantel—Cardiac disorder—Vinorelbine—ovarian cancer	0.00144	0.00636	CcSEcCtD
Praziquantel—Malaise—Topotecan—ovarian cancer	0.00143	0.00629	CcSEcCtD
Praziquantel—Immune system disorder—Vinorelbine—ovarian cancer	0.00141	0.00619	CcSEcCtD
Praziquantel—Arrhythmia—Vinorelbine—ovarian cancer	0.00139	0.00612	CcSEcCtD
Praziquantel—Anorexia—Chlorambucil—ovarian cancer	0.00138	0.00609	CcSEcCtD
Praziquantel—Myalgia—Topotecan—ovarian cancer	0.00135	0.00594	CcSEcCtD
Praziquantel—Convulsion—Melphalan—ovarian cancer	0.00134	0.00592	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00134	0.0059	CcSEcCtD
Praziquantel—Discomfort—Topotecan—ovarian cancer	0.00133	0.00587	CcSEcCtD
Praziquantel—Myalgia—Melphalan—ovarian cancer	0.00132	0.00581	CcSEcCtD
Praziquantel—Bone disorder—Epirubicin—ovarian cancer	0.00132	0.00581	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00131	0.00577	CcSEcCtD
Praziquantel—Nervous system disorder—Topotecan—ovarian cancer	0.00127	0.00558	CcSEcCtD
Praziquantel—Decreased appetite—Chlorambucil—ovarian cancer	0.00126	0.00556	CcSEcCtD
Praziquantel—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00126	0.00554	CcSEcCtD
Praziquantel—Skin disorder—Topotecan—ovarian cancer	0.00125	0.00553	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00125	0.00552	CcSEcCtD
Praziquantel—Fatigue—Chlorambucil—ovarian cancer	0.00125	0.00551	CcSEcCtD
Praziquantel—Anorexia—Topotecan—ovarian cancer	0.00123	0.00543	CcSEcCtD
Praziquantel—Skin disorder—Melphalan—ovarian cancer	0.00123	0.00541	CcSEcCtD
Praziquantel—Atrioventricular block—Epirubicin—ovarian cancer	0.00123	0.00541	CcSEcCtD
Praziquantel—Malaise—Vinorelbine—ovarian cancer	0.00122	0.00538	CcSEcCtD
Praziquantel—Bone disorder—Doxorubicin—ovarian cancer	0.00122	0.00538	CcSEcCtD
Praziquantel—Vertigo—Vinorelbine—ovarian cancer	0.00122	0.00536	CcSEcCtD
Praziquantel—Anorexia—Melphalan—ovarian cancer	0.00121	0.00531	CcSEcCtD
Praziquantel—Feeling abnormal—Chlorambucil—ovarian cancer	0.0012	0.00527	CcSEcCtD
Praziquantel—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00119	0.00523	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00118	0.00519	CcSEcCtD
Praziquantel—Urticaria—Chlorambucil—ovarian cancer	0.00115	0.00508	CcSEcCtD
Praziquantel—Myalgia—Vinorelbine—ovarian cancer	0.00115	0.00508	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00115	0.00508	CcSEcCtD
Praziquantel—Abdominal pain—Chlorambucil—ovarian cancer	0.00115	0.00505	CcSEcCtD
Praziquantel—Body temperature increased—Chlorambucil—ovarian cancer	0.00115	0.00505	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00114	0.00504	CcSEcCtD
Praziquantel—Discomfort—Vinorelbine—ovarian cancer	0.00114	0.00502	CcSEcCtD
Praziquantel—Atrioventricular block—Doxorubicin—ovarian cancer	0.00114	0.00501	CcSEcCtD
Praziquantel—Decreased appetite—Topotecan—ovarian cancer	0.00112	0.00495	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00112	0.00491	CcSEcCtD
Praziquantel—Fatigue—Topotecan—ovarian cancer	0.00111	0.00491	CcSEcCtD
Praziquantel—Decreased appetite—Melphalan—ovarian cancer	0.0011	0.00484	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00109	0.00481	CcSEcCtD
Praziquantel—Fatigue—Melphalan—ovarian cancer	0.00109	0.00481	CcSEcCtD
Praziquantel—Nervous system disorder—Vinorelbine—ovarian cancer	0.00108	0.00478	CcSEcCtD
Praziquantel—Skin disorder—Vinorelbine—ovarian cancer	0.00107	0.00473	CcSEcCtD
Praziquantel—Hypersensitivity—Chlorambucil—ovarian cancer	0.00107	0.00471	CcSEcCtD
Praziquantel—Bradycardia—Paclitaxel—ovarian cancer	0.00107	0.00469	CcSEcCtD
Praziquantel—Feeling abnormal—Topotecan—ovarian cancer	0.00106	0.00469	CcSEcCtD
Praziquantel—Gastrointestinal pain—Topotecan—ovarian cancer	0.00106	0.00465	CcSEcCtD
Praziquantel—Anorexia—Vinorelbine—ovarian cancer	0.00105	0.00464	CcSEcCtD
Praziquantel—Asthenia—Chlorambucil—ovarian cancer	0.00104	0.00459	CcSEcCtD
Praziquantel—Pruritus—Chlorambucil—ovarian cancer	0.00103	0.00452	CcSEcCtD
Praziquantel—Urticaria—Topotecan—ovarian cancer	0.00103	0.00452	CcSEcCtD
Praziquantel—Abdominal pain—Topotecan—ovarian cancer	0.00102	0.0045	CcSEcCtD
Praziquantel—Body temperature increased—Topotecan—ovarian cancer	0.00102	0.0045	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00101	0.00444	CcSEcCtD
Praziquantel—Urticaria—Melphalan—ovarian cancer	0.001	0.00443	CcSEcCtD
Praziquantel—Diarrhoea—Chlorambucil—ovarian cancer	0.000993	0.00437	CcSEcCtD
Praziquantel—Cardiac disorder—Paclitaxel—ovarian cancer	0.000971	0.00428	CcSEcCtD
Praziquantel—Decreased appetite—Vinorelbine—ovarian cancer	0.000961	0.00423	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000954	0.0042	CcSEcCtD
Praziquantel—Fatigue—Vinorelbine—ovarian cancer	0.000953	0.0042	CcSEcCtD
Praziquantel—Hypersensitivity—Topotecan—ovarian cancer	0.000952	0.00419	CcSEcCtD
Praziquantel—Immune system disorder—Paclitaxel—ovarian cancer	0.000945	0.00416	CcSEcCtD
Praziquantel—Arrhythmia—Paclitaxel—ovarian cancer	0.000935	0.00412	CcSEcCtD
Praziquantel—Hypersensitivity—Melphalan—ovarian cancer	0.000932	0.00411	CcSEcCtD
Praziquantel—Asthenia—Topotecan—ovarian cancer	0.000927	0.00408	CcSEcCtD
Praziquantel—Vomiting—Chlorambucil—ovarian cancer	0.000923	0.00407	CcSEcCtD
Praziquantel—Pruritus—Topotecan—ovarian cancer	0.000914	0.00403	CcSEcCtD
Praziquantel—Feeling abnormal—Vinorelbine—ovarian cancer	0.000911	0.00401	CcSEcCtD
Praziquantel—Asthenia—Melphalan—ovarian cancer	0.000908	0.004	CcSEcCtD
Praziquantel—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000904	0.00398	CcSEcCtD
Praziquantel—Pruritus—Melphalan—ovarian cancer	0.000895	0.00394	CcSEcCtD
Praziquantel—Diarrhoea—Topotecan—ovarian cancer	0.000884	0.00389	CcSEcCtD
Praziquantel—Urticaria—Vinorelbine—ovarian cancer	0.000878	0.00387	CcSEcCtD
Praziquantel—Abdominal pain—Vinorelbine—ovarian cancer	0.000874	0.00385	CcSEcCtD
Praziquantel—Body temperature increased—Vinorelbine—ovarian cancer	0.000874	0.00385	CcSEcCtD
Praziquantel—Diarrhoea—Melphalan—ovarian cancer	0.000865	0.00381	CcSEcCtD
Praziquantel—Nausea—Chlorambucil—ovarian cancer	0.000862	0.0038	CcSEcCtD
Praziquantel—Dizziness—Topotecan—ovarian cancer	0.000854	0.00376	CcSEcCtD
Praziquantel—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000845	0.00372	CcSEcCtD
Praziquantel—Cardiac disorder—Docetaxel—ovarian cancer	0.000823	0.00363	CcSEcCtD
Praziquantel—Vomiting—Topotecan—ovarian cancer	0.000821	0.00362	CcSEcCtD
Praziquantel—Malaise—Paclitaxel—ovarian cancer	0.000821	0.00362	CcSEcCtD
Praziquantel—Vertigo—Paclitaxel—ovarian cancer	0.000818	0.00361	CcSEcCtD
Praziquantel—Rash—Topotecan—ovarian cancer	0.000815	0.00359	CcSEcCtD
Praziquantel—Hypersensitivity—Vinorelbine—ovarian cancer	0.000814	0.00359	CcSEcCtD
Praziquantel—Dermatitis—Topotecan—ovarian cancer	0.000814	0.00359	CcSEcCtD
Praziquantel—Headache—Topotecan—ovarian cancer	0.000809	0.00357	CcSEcCtD
Praziquantel—Vomiting—Melphalan—ovarian cancer	0.000804	0.00354	CcSEcCtD
Praziquantel—Immune system disorder—Docetaxel—ovarian cancer	0.000801	0.00353	CcSEcCtD
Praziquantel—Rash—Melphalan—ovarian cancer	0.000798	0.00351	CcSEcCtD
Praziquantel—Dermatitis—Melphalan—ovarian cancer	0.000797	0.00351	CcSEcCtD
Praziquantel—Asthenia—Vinorelbine—ovarian cancer	0.000793	0.00349	CcSEcCtD
Praziquantel—Arrhythmia—Docetaxel—ovarian cancer	0.000792	0.00349	CcSEcCtD
Praziquantel—Convulsion—Paclitaxel—ovarian cancer	0.000789	0.00348	CcSEcCtD
Praziquantel—Pruritus—Vinorelbine—ovarian cancer	0.000782	0.00344	CcSEcCtD
Praziquantel—Myalgia—Paclitaxel—ovarian cancer	0.000775	0.00342	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00077	0.00339	CcSEcCtD
Praziquantel—Nausea—Topotecan—ovarian cancer	0.000767	0.00338	CcSEcCtD
Praziquantel—Discomfort—Paclitaxel—ovarian cancer	0.000766	0.00338	CcSEcCtD
Praziquantel—Diarrhoea—Vinorelbine—ovarian cancer	0.000756	0.00333	CcSEcCtD
Praziquantel—Nausea—Melphalan—ovarian cancer	0.000751	0.00331	CcSEcCtD
Praziquantel—Eosinophilia—Epirubicin—ovarian cancer	0.00074	0.00326	CcSEcCtD
Praziquantel—Dizziness—Vinorelbine—ovarian cancer	0.000731	0.00322	CcSEcCtD
Praziquantel—Nervous system disorder—Paclitaxel—ovarian cancer	0.000729	0.00321	CcSEcCtD
Praziquantel—Skin disorder—Paclitaxel—ovarian cancer	0.000722	0.00318	CcSEcCtD
Praziquantel—Anorexia—Paclitaxel—ovarian cancer	0.000709	0.00312	CcSEcCtD
Praziquantel—Vomiting—Vinorelbine—ovarian cancer	0.000703	0.0031	CcSEcCtD
Praziquantel—Rash—Vinorelbine—ovarian cancer	0.000697	0.00307	CcSEcCtD
Praziquantel—Dermatitis—Vinorelbine—ovarian cancer	0.000696	0.00307	CcSEcCtD
Praziquantel—Headache—Vinorelbine—ovarian cancer	0.000692	0.00305	CcSEcCtD
Praziquantel—Eosinophilia—Doxorubicin—ovarian cancer	0.000685	0.00302	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000677	0.00298	CcSEcCtD
Praziquantel—Convulsion—Docetaxel—ovarian cancer	0.000669	0.00295	CcSEcCtD
Praziquantel—Drowsiness—Epirubicin—ovarian cancer	0.000666	0.00294	CcSEcCtD
Praziquantel—Somnolence—Paclitaxel—ovarian cancer	0.000661	0.00291	CcSEcCtD
Praziquantel—Myalgia—Docetaxel—ovarian cancer	0.000657	0.0029	CcSEcCtD
Praziquantel—Nausea—Vinorelbine—ovarian cancer	0.000656	0.00289	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000653	0.00288	CcSEcCtD
Praziquantel—Decreased appetite—Paclitaxel—ovarian cancer	0.000646	0.00285	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000642	0.00283	CcSEcCtD
Praziquantel—Fatigue—Paclitaxel—ovarian cancer	0.000641	0.00282	CcSEcCtD
Praziquantel—Nervous system disorder—Docetaxel—ovarian cancer	0.000618	0.00272	CcSEcCtD
Praziquantel—Drowsiness—Doxorubicin—ovarian cancer	0.000617	0.00272	CcSEcCtD
Praziquantel—Feeling abnormal—Paclitaxel—ovarian cancer	0.000613	0.0027	CcSEcCtD
Praziquantel—Skin disorder—Docetaxel—ovarian cancer	0.000612	0.0027	CcSEcCtD
Praziquantel—Bradycardia—Epirubicin—ovarian cancer	0.000609	0.00268	CcSEcCtD
Praziquantel—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000608	0.00268	CcSEcCtD
Praziquantel—Anorexia—Docetaxel—ovarian cancer	0.000601	0.00265	CcSEcCtD
Praziquantel—Urticaria—Paclitaxel—ovarian cancer	0.000591	0.0026	CcSEcCtD
Praziquantel—Abdominal pain—Paclitaxel—ovarian cancer	0.000588	0.00259	CcSEcCtD
Praziquantel—Body temperature increased—Paclitaxel—ovarian cancer	0.000588	0.00259	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000574	0.00253	CcSEcCtD
Praziquantel—Bradycardia—Doxorubicin—ovarian cancer	0.000563	0.00248	CcSEcCtD
Praziquantel—Somnolence—Docetaxel—ovarian cancer	0.00056	0.00247	CcSEcCtD
Praziquantel—Cardiac disorder—Epirubicin—ovarian cancer	0.000555	0.00245	CcSEcCtD
Praziquantel—Decreased appetite—Docetaxel—ovarian cancer	0.000548	0.00241	CcSEcCtD
Praziquantel—Hypersensitivity—Paclitaxel—ovarian cancer	0.000548	0.00241	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000544	0.0024	CcSEcCtD
Praziquantel—Fatigue—Docetaxel—ovarian cancer	0.000543	0.00239	CcSEcCtD
Praziquantel—Immune system disorder—Epirubicin—ovarian cancer	0.00054	0.00238	CcSEcCtD
Praziquantel—Arrhythmia—Epirubicin—ovarian cancer	0.000534	0.00235	CcSEcCtD
Praziquantel—Asthenia—Paclitaxel—ovarian cancer	0.000533	0.00235	CcSEcCtD
Praziquantel—Pruritus—Paclitaxel—ovarian cancer	0.000526	0.00232	CcSEcCtD
Praziquantel—Feeling abnormal—Docetaxel—ovarian cancer	0.000519	0.00229	CcSEcCtD
Praziquantel—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000515	0.00227	CcSEcCtD
Praziquantel—Cardiac disorder—Doxorubicin—ovarian cancer	0.000514	0.00226	CcSEcCtD
Praziquantel—Diarrhoea—Paclitaxel—ovarian cancer	0.000509	0.00224	CcSEcCtD
Praziquantel—Immune system disorder—Doxorubicin—ovarian cancer	0.0005	0.0022	CcSEcCtD
Praziquantel—Abdominal pain—Docetaxel—ovarian cancer	0.000498	0.00219	CcSEcCtD
Praziquantel—Body temperature increased—Docetaxel—ovarian cancer	0.000498	0.00219	CcSEcCtD
Praziquantel—Arrhythmia—Doxorubicin—ovarian cancer	0.000494	0.00218	CcSEcCtD
Praziquantel—Dizziness—Paclitaxel—ovarian cancer	0.000492	0.00217	CcSEcCtD
Praziquantel—Ill-defined disorder—Epirubicin—ovarian cancer	0.000483	0.00213	CcSEcCtD
Praziquantel—Vomiting—Paclitaxel—ovarian cancer	0.000473	0.00208	CcSEcCtD
Praziquantel—Malaise—Epirubicin—ovarian cancer	0.00047	0.00207	CcSEcCtD
Praziquantel—Rash—Paclitaxel—ovarian cancer	0.000469	0.00206	CcSEcCtD
Praziquantel—Dermatitis—Paclitaxel—ovarian cancer	0.000468	0.00206	CcSEcCtD
Praziquantel—Vertigo—Epirubicin—ovarian cancer	0.000468	0.00206	CcSEcCtD
Praziquantel—Headache—Paclitaxel—ovarian cancer	0.000466	0.00205	CcSEcCtD
Praziquantel—Hypersensitivity—Docetaxel—ovarian cancer	0.000464	0.00205	CcSEcCtD
Praziquantel—Asthenia—Docetaxel—ovarian cancer	0.000452	0.00199	CcSEcCtD
Praziquantel—Convulsion—Epirubicin—ovarian cancer	0.000451	0.00199	CcSEcCtD
Praziquantel—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000447	0.00197	CcSEcCtD
Praziquantel—Pruritus—Docetaxel—ovarian cancer	0.000446	0.00196	CcSEcCtD
Praziquantel—Myalgia—Epirubicin—ovarian cancer	0.000443	0.00195	CcSEcCtD
Praziquantel—Nausea—Paclitaxel—ovarian cancer	0.000442	0.00195	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00044	0.00194	CcSEcCtD
Praziquantel—Discomfort—Epirubicin—ovarian cancer	0.000438	0.00193	CcSEcCtD
Praziquantel—Malaise—Doxorubicin—ovarian cancer	0.000434	0.00191	CcSEcCtD
Praziquantel—Vertigo—Doxorubicin—ovarian cancer	0.000433	0.00191	CcSEcCtD
Praziquantel—Diarrhoea—Docetaxel—ovarian cancer	0.000431	0.0019	CcSEcCtD
Praziquantel—Convulsion—Doxorubicin—ovarian cancer	0.000417	0.00184	CcSEcCtD
Praziquantel—Nervous system disorder—Epirubicin—ovarian cancer	0.000417	0.00184	CcSEcCtD
Praziquantel—Dizziness—Docetaxel—ovarian cancer	0.000417	0.00184	CcSEcCtD
Praziquantel—Skin disorder—Epirubicin—ovarian cancer	0.000413	0.00182	CcSEcCtD
Praziquantel—Myalgia—Doxorubicin—ovarian cancer	0.00041	0.00181	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000407	0.00179	CcSEcCtD
Praziquantel—Discomfort—Doxorubicin—ovarian cancer	0.000405	0.00179	CcSEcCtD
Praziquantel—Anorexia—Epirubicin—ovarian cancer	0.000405	0.00178	CcSEcCtD
Praziquantel—Vomiting—Docetaxel—ovarian cancer	0.000401	0.00177	CcSEcCtD
Praziquantel—Rash—Docetaxel—ovarian cancer	0.000397	0.00175	CcSEcCtD
Praziquantel—Dermatitis—Docetaxel—ovarian cancer	0.000397	0.00175	CcSEcCtD
Praziquantel—Headache—Docetaxel—ovarian cancer	0.000395	0.00174	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000387	0.00171	CcSEcCtD
Praziquantel—Nervous system disorder—Doxorubicin—ovarian cancer	0.000386	0.0017	CcSEcCtD
Praziquantel—Skin disorder—Doxorubicin—ovarian cancer	0.000382	0.00168	CcSEcCtD
Praziquantel—Somnolence—Epirubicin—ovarian cancer	0.000378	0.00166	CcSEcCtD
Praziquantel—Anorexia—Doxorubicin—ovarian cancer	0.000375	0.00165	CcSEcCtD
Praziquantel—Nausea—Docetaxel—ovarian cancer	0.000374	0.00165	CcSEcCtD
Praziquantel—Decreased appetite—Epirubicin—ovarian cancer	0.000369	0.00163	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000367	0.00162	CcSEcCtD
Praziquantel—Fatigue—Epirubicin—ovarian cancer	0.000366	0.00161	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000358	0.00158	CcSEcCtD
Praziquantel—Feeling abnormal—Epirubicin—ovarian cancer	0.00035	0.00154	CcSEcCtD
Praziquantel—Somnolence—Doxorubicin—ovarian cancer	0.00035	0.00154	CcSEcCtD
Praziquantel—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000348	0.00153	CcSEcCtD
Praziquantel—Decreased appetite—Doxorubicin—ovarian cancer	0.000342	0.00151	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000339	0.0015	CcSEcCtD
Praziquantel—Fatigue—Doxorubicin—ovarian cancer	0.000339	0.00149	CcSEcCtD
Praziquantel—Urticaria—Epirubicin—ovarian cancer	0.000338	0.00149	CcSEcCtD
Praziquantel—Abdominal pain—Epirubicin—ovarian cancer	0.000336	0.00148	CcSEcCtD
Praziquantel—Body temperature increased—Epirubicin—ovarian cancer	0.000336	0.00148	CcSEcCtD
Praziquantel—Feeling abnormal—Doxorubicin—ovarian cancer	0.000324	0.00143	CcSEcCtD
Praziquantel—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000322	0.00142	CcSEcCtD
Praziquantel—Hypersensitivity—Epirubicin—ovarian cancer	0.000313	0.00138	CcSEcCtD
Praziquantel—Urticaria—Doxorubicin—ovarian cancer	0.000312	0.00138	CcSEcCtD
Praziquantel—Body temperature increased—Doxorubicin—ovarian cancer	0.000311	0.00137	CcSEcCtD
Praziquantel—Abdominal pain—Doxorubicin—ovarian cancer	0.000311	0.00137	CcSEcCtD
Praziquantel—Asthenia—Epirubicin—ovarian cancer	0.000305	0.00134	CcSEcCtD
Praziquantel—Pruritus—Epirubicin—ovarian cancer	0.000301	0.00132	CcSEcCtD
Praziquantel—Diarrhoea—Epirubicin—ovarian cancer	0.000291	0.00128	CcSEcCtD
Praziquantel—Hypersensitivity—Doxorubicin—ovarian cancer	0.00029	0.00128	CcSEcCtD
Praziquantel—Asthenia—Doxorubicin—ovarian cancer	0.000282	0.00124	CcSEcCtD
Praziquantel—Dizziness—Epirubicin—ovarian cancer	0.000281	0.00124	CcSEcCtD
Praziquantel—Pruritus—Doxorubicin—ovarian cancer	0.000278	0.00123	CcSEcCtD
Praziquantel—Vomiting—Epirubicin—ovarian cancer	0.00027	0.00119	CcSEcCtD
Praziquantel—Diarrhoea—Doxorubicin—ovarian cancer	0.000269	0.00119	CcSEcCtD
Praziquantel—Rash—Epirubicin—ovarian cancer	0.000268	0.00118	CcSEcCtD
Praziquantel—Dermatitis—Epirubicin—ovarian cancer	0.000268	0.00118	CcSEcCtD
Praziquantel—Headache—Epirubicin—ovarian cancer	0.000266	0.00117	CcSEcCtD
Praziquantel—Dizziness—Doxorubicin—ovarian cancer	0.00026	0.00115	CcSEcCtD
Praziquantel—Nausea—Epirubicin—ovarian cancer	0.000252	0.00111	CcSEcCtD
Praziquantel—Vomiting—Doxorubicin—ovarian cancer	0.00025	0.0011	CcSEcCtD
Praziquantel—Rash—Doxorubicin—ovarian cancer	0.000248	0.00109	CcSEcCtD
Praziquantel—Dermatitis—Doxorubicin—ovarian cancer	0.000248	0.00109	CcSEcCtD
Praziquantel—Headache—Doxorubicin—ovarian cancer	0.000246	0.00109	CcSEcCtD
Praziquantel—Nausea—Doxorubicin—ovarian cancer	0.000234	0.00103	CcSEcCtD
